Shares in Proton beam therapy specialist Advanced Oncotherapy (AVO) have been suspended from trading on AIM after talks to raise an additional £8m in funding collapsed. The company said it was now in a ‘highly constrained financial position and requires additional financing urgently in order to continue as a going concern’. AVO had been in…